Aprea Therapeutics, Inc.
APRENasdaqCIK 1781983HealthcareFiscal year ends Dec 31
Reports and events: 146 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-102795 |
| 2026-08-1208:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094544 |
| 2026-08-1208:35 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-094542 |
| 2026-07-2316:05 ET | 8-K | 3.01 Delisting notice | 0001104659-26-086254 |
| 2026-06-1716:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-075151 |
| 2026-05-1306:46 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059743 |
| 2026-05-1306:35 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-059734 |
| 2026-04-3006:35 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001104659-26-052044 |
| 2026-04-0108:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-038258 |
| 2026-03-3017:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036821 |
| 2026-03-1608:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-028068 |
| 2026-03-1608:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028046 |
| 2026-02-1808:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-016797 |
| 2026-01-2916:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-007988 |
| 2026-01-2316:45 ET | 8-K | 3.01 Delisting notice | 0001104659-26-006267 |
| 2026-01-0916:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002490 |
| 2025-12-0916:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-119680 |
| 2025-11-1208:40 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109867 |
| 2025-11-1208:35 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-109860 |
| 2025-10-2408:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-102004 |
| 2025-10-1508:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099534 |
| 2025-09-0807:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011909 |
| 2025-08-1208:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011152 |
| 2025-08-1208:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-011149 |
| 2025-06-0916:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-057807 |
| 2025-05-1408:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007667 |
| 2025-05-1408:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-007665 |
| 2025-04-2216:05 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001558370-25-005141 |
| 2025-03-2508:45 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003588 |
| 2025-03-2508:40 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-003587 |
| 2025-02-0508:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000641 |
| 2025-01-1308:00 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000155 |
| 2024-11-0816:36 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-115911 |
| 2024-11-0708:38 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-014768 |
| 2024-11-0708:35 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014767 |
| 2024-10-2309:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013486 |
| 2024-10-0908:45 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-107219 |
| 2024-08-1208:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-011808 |
| 2024-08-1208:35 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011806 |
| 2024-06-2016:15 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-073396 |
| 2024-06-1708:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009225 |
| 2024-05-1408:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-008070 |
| 2024-05-1408:35 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-008069 |
| 2024-04-2507:00 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001558370-24-005678 |
| 2024-04-1016:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-004927 |
| 2024-03-2608:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-003887 |
| 2024-03-2607:45 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-003886 |
| 2024-03-1216:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-033494 |
| 2024-02-0617:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-000818 |
| 2024-02-0216:26 ET | 8-K | 2.02 Results of operations | 0001104659-24-010057 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.